Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology

May 3, 2022 updated by: Breiffni Leavy, Stiftelsen Stockholms Sjukhem

Continued Support for Physical Activity in Everyday Life With Parkinson's Disease Using eHealth Technology

The purpose of this study is to test the feasibility of a novel motor-cognitive home training intervention using eHealth technology among people with Parkinson's Disease

Study Overview

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 112 19
        • Stockholms sjukhem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Neurologist diagnosed Idiopathic PD at least 6 months previous to inclusion.
  • Hoehn & Yahr stages I-III
  • Stable in anti-Parkinson medications three months prior to inclusion.
  • The ability to walk walk independently indoors without a walking aid.
  • The ability to walk continually with/without a walking aid for at least 5 minutes.

Exclusion Criteria:

  • Cognitive impairment affecting the ability to understand or follow verbal or written instructions (Montreal Cognitive Assessment ≤ 21 points).
  • Impaired vision and/or impaired communication which hinders participation.
  • Major problems with freezing and/or two or more falls in the month previous to inclusion.
  • Other existing neurological/ orthopedic or cardiovascular disease which impedes the performance of unsupervised exercise in the home.
  • No internet connection in the home.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Home training
Participants train 3 times weekly in their home environment with help of a digital training app, over a 10-week period.

Participants engage in a progressive 10-week exercise program targeted at improving motor and cognitive function. Motor exercises target functional strength, gait and physical activity level. Training sessions occur 3 times weekly and supported by a digital application which has been adapted for people with Parkinson's disease. Weeks 1-2 focus solely on motor exercises. Dual-task (Motor-cognitive) exercises are introduced at week 3 and progressed until week 10. Participants are also encouraged to increase the physical activity levels during the 10 week period.

Weekly contact is made using the video function/ telephone with clinical specialists/ researchers. Two home visits will occur, the first one week prior to the intervention and at the 5-week period. Participants receive motivational messaging and reminders via the app during the intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction with the eHealth intervention
Time Frame: 10-week period.
Participants will rate their satisfaction with using a digital survey following each training session. An average value will be calculated. This will measure the feasibility outcome - Acceptability of the intervention.
10-week period.
Participants perceived intensity of the motor exercises
Time Frame: 10-week period.
Participants will rate the intensity of the intervention using the Borg Rating of perceived, Exertion Scale (6-20) following each training session. According to this scale, lower numbers signify lower levels of exertion, and higher numbers signify higher levels of exertion. The aim is that participants levels of exertion will lie in the middle range (12-17) This will measure the feasibility outcome - Practicality or Ability to carry out the intervention.
10-week period.
Participants perceived difficulty of the motor-cognitive (dual-task) exercises
Time Frame: 10-week period.
Participants will rate the difficulty of the dual-task exercises using a 0-10 scale (higher scores = higher degree of difficulty) following each exercise session and scores will be averaged over the study period following. This will measure the feasibility outcome - Suitability of the intervention.
10-week period.
Participants actual use of the eHealth training tool
Time Frame: 10-week period.
Total time logged in to the digital training app will be derived from system and expressed as a percentage of total recommended intervention time. This will measure the feasibility outcome - Demand of the intervention'.
10-week period.
Total number of adverse events during the training sessions
Time Frame: 10 week period
Participants will report all adverse events such as falls or other injuries acquired during the training session, during a once weekly telephone interview. This will measure the feasibility outcome Safety.
10 week period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Habitual physical activity
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Measured by the ActiGraph accelerometer model GT3X+ (ActiGraph, Pensacola, FL, US) worn on the hip for seven consecutive days
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Usual and fast walking speed
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
10 meter walk test at self-selected and fast speeds respectively
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Functional capacity as well as dual task gait ability
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Assessed during the 2 minute walk test (2MWT) in single and dual task conditions
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Self-reported walk ability
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Walk-12 G Questionnaire
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Lower extremity function
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
30 second chair stand test
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Balance performance
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Mini Balance Evaluation Systems Test (Mini-BESTest)
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Self-reported balance confidence
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Activity-specific Balance Confidence (ABC) scale
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Self-reported difficulties across 8 dimensions of daily living
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
The Parkinson's Disease Questionnaire -39 (PDQ-39)
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Exercise self-efficacy
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Swedish Exercise Self-Efficacy Scale (S-ESES)
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Executive Function
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Attention and psychomotor processing speed will be assessed by the Trail making test (TMT) conditions 2 (letter Sequencing) and 4 (number-Letter Switching (set-shifting)) from Delis-Kaplan Executive Function System (D-KEFS). Results are presented as time in seconds.
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Verbal Fluency
Time Frame: i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)
Verbal function, initiation & task-set switching will be assessed by the Verbal fluency (Letter Fluency, Category Fluency, and Category Switching) from Delis-Kaplan Executive Function System (D-KEFS). Raw scores are converted to scaled scores.
i) Baseline, pre-intervention. ii) Immediately after the intervention (10-week home training)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Breiffni Leavy, PhD, Stockholms sjukhem and Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 5, 2021

Primary Completion (Actual)

January 14, 2022

Study Completion (Actual)

January 14, 2022

Study Registration Dates

First Submitted

August 12, 2021

First Submitted That Met QC Criteria

August 24, 2021

First Posted (Actual)

August 30, 2021

Study Record Updates

Last Update Posted (Actual)

May 4, 2022

Last Update Submitted That Met QC Criteria

May 3, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telerehabilitation

Clinical Trials on Motor-cognitive exercise therapy in the home

Subscribe